Synlogic (SYBX)
(Delayed Data from NSDQ)
$1.60 USD
-0.05 (-3.03%)
Updated May 22, 2024 04:00 PM ET
After-Market: $1.64 +0.04 (2.50%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth A Momentum D VGM
Brokerage Reports
0 items in cart
Synlogic, Inc. [SYBX]
Reports for Purchase
Showing records 41 - 60 ( 110 total )
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
COVID-19 Impact on Coverage Universe: Week of April 20 Update
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
COVID-19 Impact on Coverage Universe: Week of April 13 Update
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
COVID-19 Impact on Coverage Universe: Week of March 30 Update
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
COVID-19 Impact on Coverage Universe: Week of March 30 Update
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
2019 Financials Reported; Strong Balance Sheet; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
SYBX Adding to the Pipeline, Upcoming PKU and More
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
2020 Milestones; Pipeline Expansion; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Bridging Study Data Appears Favorable; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Management Changes; SYNB1618 Phase 1/2a Data Presented; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Biomarker Data has Promise, Solid Oral Formulation Needs to Deliver
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D